Greenland Mines Ltd. (NASDAQ: GRML) has announced the completion of its 2026 bathymetric survey at the Skaergaard Project in southeast Greenland, a key milestone that enhances the company's understanding of the fjord systems and supports future operational planning. The survey covered more area than originally planned, producing high-resolution seabed data across the fjords surrounding the project. This data has already been used to guide the company's support vessel to a new anchorage within 500 meters of the initial 2026 operational area, demonstrating immediate practical application.
The bathymetric data is expected to support the creation of new official navigational charts, a dedicated navigational safety study, and planning for future large-scale marine shipping operations. This is crucial for a project located in a remote, ice-prone region where marine logistics are a significant component of operational feasibility. By improving navigational safety and efficiency, the survey reduces risk and lays the groundwork for the transportation of equipment, supplies, and eventually, product.
In addition to the survey, Greenland Mines has completed all HQ-diameter drill core required for its planned multiton metallurgical bulk sample. The transition to NQ-size core drilling for resource definition and geotechnical work marks the next phase of the 2026 field program. A new core shack for logging, sampling, and storage is now fully operational, enhancing the company's on-site capabilities. These activities are part of a broader 2026 field program encompassing resource definition drilling, metallurgical bulk sampling, environmental baseline studies, and infrastructure planning.
The Skaergaard Project is a significant asset for Greenland Mines, which has two operating divisions: Mining and Biotech. The mining division focuses on the exploration and development of the Skaergaard Project and, subject to closing of a previously announced transaction, the Sarfartoq neodymium-praseodymium (Nd-Pr) rare earths project in southwest Greenland. The biotech division includes Klotho's KLTO-202 primary indication for ALS. The company's strategy is centered on building a multi-asset platform with exposure to rare earth magnet materials, precious metals, and selected midstream processing opportunities, while advancing its broader North Atlantic Critical Metals Corridor vision.
The completion of the bathymetric survey and the progress in drilling are critical steps toward the company's goal of completing an Initial Assessment. The data collected will inform not only navigational planning but also environmental baseline studies and infrastructure planning, all of which are essential for advancing the project. The company's focus on detailed data collection and operational efficiency underscores its commitment to responsible and feasible project development in a challenging environment.
For more information on this announcement, visit the full press release at https://ibn.fm/vk7G8.
